Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

Approval Number

国药准字H20233064

Company深圳大佛药业股份有限公司

Registration Date

January 19, 2023

Drug Information

Generic Name

盐酸左沙丁胺醇雾化吸入溶液

Dosage Form

吸入制剂

Strength

3ml：0.31mg（按C₁₃H₂₁NO₃计）

Drug Type

化学药品

Registration Date

January 19, 2023

Company Information

Applicant Company

Company Name深圳大佛药业股份有限公司

Company Address

深圳市坪山新区坑梓街道金辉路14号深圳市生物医药创新产业园区6号楼

Manufacturing Company

Company Name浙江赛默制药有限公司

Company Address

浙江省金华市婺城区汤溪镇永湖街788号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy